Lmcg Investments LLC Acquires 3,480 Shares of Agilent Technologies, Inc. (NYSE:A)

Lmcg Investments LLC raised its holdings in shares of Agilent Technologies, Inc. (NYSE:A) by 4.6% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 79,091 shares of the medical research company’s stock after buying an additional 3,480 shares during the period. Lmcg Investments LLC’s holdings in Agilent Technologies were worth $10,253,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Crewe Advisors LLC raised its holdings in Agilent Technologies by 114.8% during the 2nd quarter. Crewe Advisors LLC now owns 189 shares of the medical research company’s stock valued at $25,000 after buying an additional 101 shares during the period. Livelsberger Financial Advisory purchased a new stake in shares of Agilent Technologies during the fourth quarter valued at about $26,000. Ridgewood Investments LLC acquired a new position in shares of Agilent Technologies during the second quarter worth $29,000. Rise Advisors LLC raised its stake in Agilent Technologies by 527.8% in the first quarter. Rise Advisors LLC now owns 226 shares of the medical research company’s stock valued at $33,000 after buying an additional 190 shares during the last quarter. Finally, YHB Investment Advisors Inc. acquired a new stake in Agilent Technologies in the 1st quarter worth approximately $34,000. Institutional investors own 87.42% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts have recently weighed in on A shares. Bank of America increased their price objective on shares of Agilent Technologies from $140.00 to $147.00 and gave the stock a “neutral” rating in a research note on Thursday, August 22nd. JPMorgan Chase & Co. lowered their price objective on Agilent Technologies from $165.00 to $155.00 and set an “overweight” rating on the stock in a report on Thursday, May 30th. Citigroup raised their price target on shares of Agilent Technologies from $150.00 to $165.00 and gave the stock a “buy” rating in a research note on Thursday, August 22nd. Jefferies Financial Group restated a “hold” rating and issued a $135.00 target price (down from $152.00) on shares of Agilent Technologies in a report on Monday, June 3rd. Finally, Stifel Nicolaus restated a “buy” rating and issued a $151.00 target price on shares of Agilent Technologies in a research report on Monday, August 26th. One investment analyst has rated the stock with a sell rating, six have issued a hold rating and nine have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $141.60.

Insiders Place Their Bets

In other news, CEO Padraig Mcdonnell sold 1,958 shares of the business’s stock in a transaction dated Thursday, August 22nd. The stock was sold at an average price of $145.00, for a total value of $283,910.00. Following the completion of the sale, the chief executive officer now directly owns 24,118 shares of the company’s stock, valued at approximately $3,497,110. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 0.33% of the company’s stock.

Agilent Technologies Stock Performance

Shares of A stock opened at $138.31 on Tuesday. The company has a market cap of $40.35 billion, a P/E ratio of 32.70, a PEG ratio of 6.43 and a beta of 1.05. The company has a current ratio of 1.78, a quick ratio of 1.37 and a debt-to-equity ratio of 0.36. The firm has a fifty day moving average price of $137.00 and a 200 day moving average price of $139.25. Agilent Technologies, Inc. has a 12 month low of $96.80 and a 12 month high of $155.35.

Agilent Technologies (NYSE:A) last released its quarterly earnings data on Wednesday, August 21st. The medical research company reported $1.32 earnings per share for the quarter, topping analysts’ consensus estimates of $1.26 by $0.06. Agilent Technologies had a net margin of 21.75% and a return on equity of 25.26%. The company had revenue of $1.58 billion for the quarter, compared to analysts’ expectations of $1.56 billion. During the same quarter last year, the company earned $1.43 earnings per share. The firm’s revenue for the quarter was down 5.6% on a year-over-year basis. Sell-side analysts predict that Agilent Technologies, Inc. will post 5.24 earnings per share for the current fiscal year.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.